≥98% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Protected from light,Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Palazestrant is an antiestrogen and antineoplastic agent. Palazestrant can completely inhibit the activity of 17b-estradiol (E2) with IC50 value of 6.4 nM, and inhibit the proliferation of MCF7 and CAMA-1 cells with IC50 value of 1.4-1.6 nM. Palazestrant can inhibit ER+/HER2+ cancer
| Molecular Weight | 449.60 |
|---|
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 F2512423 | Certificate of Analysis | Nov 05, 2024 | P757084 |
| F2512424 | Certificate of Analysis | Nov 05, 2024 | P757084 |
| F2512425 | Certificate of Analysis | Nov 05, 2024 | P757084 |
| F2512426 | Certificate of Analysis | Nov 05, 2024 | P757084 |
| F2512427 | Certificate of Analysis | Nov 05, 2024 | P757084 |
| F2512428 | Certificate of Analysis | Nov 05, 2024 | P757084 |
| F2512466 | Certificate of Analysis | Nov 05, 2024 | P757084 |
| F2512467 | Certificate of Analysis | Nov 05, 2024 | P757084 |
| F2512468 | Certificate of Analysis | Nov 05, 2024 | P757084 |
| Sensitivity | light sensitive |
|---|
